Latest Breaking News On - Maha katabi - Page 3 : vimarsana.com

Vera Therapeutics (NASDAQ:VERA) Trading Down 5 9%

Vera Therapeutics (NASDAQ:VERA) Trading Down 5 9%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesMaha katabiCapital partnersVera therapeutics incBarclays plcCantor fitzgeraldVanguard group incGoldman sachs group incVera therapeuticsGet free reportTherapeutics trading downDirector maha katabiSachs groupVera therapeutics daily

Vera Therapeutics (VERA) Buy Rating Reiterated at Guggenheim

Vera Therapeutics (VERA) Buy Rating Reiterated at Guggenheim
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Maha katabiRaymond jamesSecurities exchange commissionCantor fitzgeraldCapital partnersVanguard group incGoldman sachs group incBarclays plcVera therapeutics incVera therapeuticsGet free reportExchange commissionDirector maha katabiSachs groupVera therapeutics daily

Vera Therapeutics, Inc (NASDAQ:VERA) Receives $28 14 Average Target Price from Analysts

Vera Therapeutics, Inc (NASDAQ:VERA) Receives $28 14 Average Target Price from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesMaha katabiBarclays plcCapital partnersVera therapeutics company profileGoldman sachs group incVanguard group incVera therapeutics incCantor fitzgeraldVera therapeuticsGet free reportTherapeutics trading downDirector maha katabiSachs groupGet freeVera therapeutics daily

Vera Therapeutics, Inc (NASDAQ:VERA) Director Maha Katabi Sells 81,009 Shares

Vera Therapeutics, Inc (NASDAQ:VERA) Director Maha Katabi Sells 81,009 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Maha katabiRaymond jamesTower research capitalVera therapeutics incCantor fitzgeraldLife insurance coRoyal bankJpmorgan chase coAmeritas investment partners incVera therapeuticsGet free reportDirector maha katabiResearch capitalInvestment partnersVera therapeutics daily

Wedbush Raises Vera Therapeutics (NASDAQ:VERA) Price Target to $34 00

Vera Therapeutics (NASDAQ:VERA – Free Report) had its price objective boosted by Wedbush from $21.00 to $34.00 in a research report sent to investors on Thursday, Benzinga reports. They currently have a neutral rating on the stock. A number of other analysts also recently issued reports on the stock. Raymond James raised shares of Vera […]

Raymond jamesMaha katabiJpmorgan chase coSecurities exchange commissionRoyal bankCantor fitzgeraldLife insurance coAmeritas investment partners incVera therapeutics incVera therapeuticsFree reportExchange commissionDirector maha katabiInvestment partnersAmalgamated bankGet free report